Verastem Stock Analysis

Verastem Stock Analysis Notes

About 88.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 4.28. Verastem had not issued any dividends in recent years. The entity had 1:12 split on the 1st of June 2023. Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. The company was incorporated in 2010 and is headquartered in Needham, Massachusetts. Verastem operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 48 people. For more information please call Daniel Paterson at 781 292 4200 or visit https://www.verastem.com.

Verastem Investment Alerts

Verastem Largest EPS Surprises

View All Earnings Estimates

Verastem Environmental, Social, and Governance (ESG) Scores

Verastem Stock Institutional Investors

Note, although Verastem's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Verastem Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 502.38 M.

Verastem Profitablity

Management Efficiency

Verastem has return on total asset (ROA) of (0.6606) % which means that it has lost $0.6606 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (28.8871) %, meaning that it created substantial loss on money invested by shareholders. Verastem's management efficiency ratios could be used to measure how well Verastem manages its routine affairs as well as how well it operates its assets and liabilities. As of the 10th of February 2026, Return On Equity is likely to grow to 5.46, though Return On Tangible Assets are likely to grow to (1.41). At this time, Verastem's Fixed Asset Turnover is very stable compared to the past year. As of the 10th of February 2026, Asset Turnover is likely to grow to 0.18, while Other Assets are likely to drop about 326.7 K.

Technical Drivers

As of the 10th of February, Verastem has the Variance of 23.35, risk adjusted performance of (0.02), and Coefficient Of Variation of (3,195). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Verastem, as well as the relationship between them. Please validate Verastem market risk adjusted performance and treynor ratio to decide if Verastem is priced more or less accurately, providing market reflects its prevalent price of 6.65 per share. Given that Verastem has information ratio of (0.05), we advise you to double-check Verastem's current market performance to make sure the company can sustain itself at a future point.

Verastem Price Movement Analysis

Verastem Insider Trading Activities

Verastem Outstanding Bonds

Verastem Predictive Daily Indicators

Verastem Corporate Filings

Verastem Forecast Models

Verastem's time-series forecasting models are one of many Verastem's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Verastem's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Verastem Bond Ratings

Verastem financial ratings play a critical role in determining how much Verastem have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Verastem's borrowing costs.

Verastem Debt to Cash Allocation

Verastem currently holds 42.25 M in liabilities with Debt to Equity (D/E) ratio of 0.5, which is about average as compared to similar companies. Verastem has a current ratio of 4.77, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Verastem's use of debt, we should always consider it together with its cash and equity.

Verastem Total Assets Over Time

Verastem Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Verastem uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Verastem Debt Ratio

34.0

It appears that about 66% of Verastem's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Verastem's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Verastem, which in turn will lower the firm's financial flexibility.

Verastem Corporate Bonds Issued

Verastem Net Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how Verastem prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Verastem shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Verastem. By using and applying Verastem Stock analysis, traders can create a robust methodology for identifying Verastem entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Verastem analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Verastem analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Verastem stock analysis indicators help investors evaluate how Verastem stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Verastem shares will generate the highest return on investment. By understating and applying Verastem stock analysis, traders can identify Verastem position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Verastem's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.